Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Protein Protects Against DNA Damage in the Developing Brain and May Act as a Tumor Suppressor

By LabMedica International staff writers
Posted on 10 May 2012
Scientists discovered that the protein TopBP1 (human DNA topoisomerase II-binding protein 1) is crucial for preventing the accumulation of DNA damage early in brain formation and in addition may serve as a tumor suppressor.

St. More...
Jude Children’s Research Hospital (Memphis, TN, USA) scientists have demonstrated that the protein TopBP1 protects early brain cells from DNA damage. Such damage might indicate later problems, including cancer.

Researchers showed that cells in the developing brain require TopBP1 to prevent DNA strands from breaking as the molecule is copied before the cell division process. Investigators also reported that stem cells and immature cells known as progenitor cells involved at the beginning of brain development are more sensitive to unrepaired DNA damage than progenitor cells later in the process. Although more developmentally advanced than stem cells, progenitor cells retain the ability to become one of a range of more specialized neurons.

“Such DNA strand breaks have great potential for creating mutations that push a normal cell toward malignancy,” said Peter McKinnon, PhD, a St. Jude department of genetics member and the article’s senior author. “When we selectively knocked out TopBP1 in mice, the amount of DNA damage we saw suggests that TopBP1 is likely to be a tumor suppressor. We are exploring that question now.”

The research appeared in the April 22, 2012, online edition of the journal Nature Neuroscience. The research builds on Dr. McKinnon’s study of DNA repair systems, including the enzymes ATM and ATR, which are associated with a devastating cancer-prone neurodegenerative disease in children called ataxia telangiectasia, and a neurodevelopmental disorder called Seckel syndrome.

TopBP1 was known to activate ATR. Earlier laboratory studies by other investigators also suggested that activation made TopBP1 invaluable for DNA replication and cell proliferation. This study, however, revealed that was not the case. Most progenitor cells in the embryonic mouse brain kept dividing after investigators inactivated the TopBP1 gene.

“We showed that rather than being fundamentally important for building the machinery of replication, TopBP1’s role is to monitor DNA damage and act when DNA damage occurs during replication,” Dr. McKinnon said. The findings provide clues into normal brain development, DNA damage repair processes, and cancer biology.

For this study, researchers monitored the impact of TopBP1 loss in progenitor cells at different stages in the developing mouse brain. The damage was most severe when the protein was knocked out in early progenitor cells. These rapidly dividing cells yield the next generations of progenitor cells that give rise to structures in the cortex involved in memory, movement, vision, and sensation. When TopBP1 was knocked out silenced in the early progenitor cells, the cortex never developed. When TopBP1 was silenced a day or two later in progenitor cells responsible for completing brain and nervous system development, the defects were present but less severe.

The progenitor cells that were created after the loss of TopBP1 were similarly full of broken strands of DNA. In both the early and later progenitor cells, unrepaired DNA damage triggered the p53 gene that activated the cell’s suicide pathway.

Researchers employed low-dose radiation to show that early progenitor cells were more sensitive to the DNA strand breaks than were progenitor cells created a day or two later. Although the cells suffered comparable damage, the damage was more apt to trigger apoptosis in the earliest progenitor cells. “This raises the likelihood that there is a different threshold to DNA damage in the early-born progenitors,” researchers noted.

Dr. McKinnon added, “These early progenitor cells give rise to the cells that go on to make various brain structures, so it is really important that there are no errors in the blueprint of these starting cells. These findings show that TopBP1 plays a critical role in maintaining the integrity of the genome.”

TopBP1 is not the only protein responsible for repairing broken DNA strands, but this study suggests it plays a unique role. When researchers turned off two other key repair factors, the proteins Lig4 and Xrcc1, in the cortex of developing mice, the loss resulted in much less severe defects than when TopBP1 was lost.

Related Links:

St. Jude Children’s Research Hospital






Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Online QC Software
Acusera 24•7
Chromogenic Culture System
InTray™ COLOREX™ ECC
Clinical Informatics Platform
CLARION™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Characterization of EV separated by distinct methods (Photo courtesy of Yuanyuan Liu, Yanbin Guo et al. Engineering, doi.org/10.1016/j.eng.2025.12.009)

Liquid Biopsy Biomarkers May Improve Childhood Epilepsy Diagnosis

Childhood epilepsy remains a major neurological disorder with unmet needs for accurate, non-invasive biomarkers, as conventional tests such as electroencephalography and neuroimaging can have limited sensitivity... Read more

Molecular Diagnostics

view channel
Image: Associate Professor Arutha Kulasinghe and non-small cell lung cancer cell (Photo courtesy of The University of Queensland)

Blood-Based Proteomic Test May Predict Treatment Response in Non-Small Cell Lung Cancer

Lung cancer remains the leading cause of cancer death, with non-small cell lung cancer (NSCLC) accounting for most cases. Treatment decisions are often made without a clear indication of how a patient... Read more

Pathology

view channel
Image: Immune-related signals in routine bone marrow biopsy slides could help predict multiple myeloma outcomes and support more personalized treatment strategies (image credit: Shutterstock)

AI Tool Extracts Immune Signals from Biopsy to Inform Myeloma Therapy

Multiple myeloma is a bone marrow malignancy in which patients can respond very differently to the same treatments, making initial therapy decisions difficult. Clinicians must choose among options such... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.